|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 538.84 USD | +1.11% |
|
+4.08% | +10.59% |
| 08-06 | United Therapeutics Insider Sold Shares Worth $4,927,985, According to a Recent SEC Filing | MT |
| 08-06 | MannKind's Diversified Portfolio Seen Leading to Higher Revenue in H2, Wedbush Says | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Neutral | Bullish |
| Resistance | 563.7 | 596.76 | 588.38 |
| Spread/Res. | -4.41% | -9.71% | -8.42% |
| Spread/Supp. | +4.36% | +13.89% | +28.73% |
| Support | 516.31 | 473.12 | 418.58 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- UTHR Stock
- Charts United Therapeutics Corporation
Select your edition
All financial news and data tailored to specific country editions
